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INTRODUCTION
The significance of reactions to scratch tests performed with 0.85, 0.75, 0.50,
and 0.25 per cent solutions of ragweed pollens purified according to our technic
has been reported (1, 2). The incidence of positive reactions of no concurrent
clinical significance was determined to be 2.63 1.16 per cent with the 0.85,
0.75, and 0.50 per cent solutions, and 2.11 1.04 per cent with the 0.25 per
cent solutions. The incidence of positive reactions in patients with fall hay
fever, asthma, or both was found to be 95.38 2.60 per cent with the 0.85, 0.75,
and 0.50 per cent solutions, and 83.08 4.65 per cent with the 0.25 per cent
solutions. Positive reactions to scratch tests with these concentrations of solu-
tions of purified ragweed pollens were diagnostic of allergic disease attributable
to the pollens in 97.32 1.61 per cent to 97.52 1.56 per cent of instances in
which they occurred.
The purpose of the present investigation is to evaluate the significance of
reactions to intracutaneous tests performed with solutions of these purified
extracts of ragweed pollens.
TEST METHOD
Two groups of patients were studied. The first was a control series consisting
of 80 consecutive patients who gave negative histories, present and past, for
hay fever, asthma, urticaria, eczema, seasonal or recurrent coryza, seasonal or
recurrent bronchitis, and nasal obstruction. The second series consisted of
45 consecutive patients with fall hay fever, asthma, or both. In the second
group of patients the allergic disease was presumably always caused by hyper-
sensitivity to ragweed pollens.
Injections were placed vertically on the lateral aspects of the arm, at least
two inches apart, and were made as superficially as possible. Approximately
0.01 cc. was injected into each test site. Solutions of purified pollen extract of
the following concentrations were used: 0.02, 0.004, 0.002, 0.001, 0.0002, 0.0001,
0.00002, 0.00001, and 0.000001 per cent. These represent serial dilutions (made
with normal saline containing 0.4 per cent phenol by weight) of a 0.75 per cent
solution of purified pollen in a 50 per cent solution of glycerin in normal saline.
Consequently, the glycerin content of the test solutions was very slight, e.g.,
the 0.02 per cent solution of pollen contained 1.34 per cent glycerin by volume;
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the 0.004 per cent solution contained 0.27 per cent glycerin by volume; etc.
The control solution was a solution of 1.34 per cent glycerin by volume in normal
saline containing 0.4 per cent phenol by weight.
In order to avoid "contamination" from other concentrations, a designated
set of syringes and needles was used for each different concentration of ragweed
solution and for the control solution.
Readings were made at the end of twelve to fifteen minutes.
Reactions were estimated as positive, doubtful, or negative.
DISCUSSION
The significantly greater incidence of positive skin reactions with each con-
centration of the extract in the hay fever and/or asthma series than in the con-
trol Series justifies the conclusion that the positive reactions are allergic in
character (table 1).
The incidence of allergic skin reactions found in patients in the control series
varied with the concentration of the test solution. Such reactions were found
in patients in this series in 10 3.35 per cent of cases with the 0.02 per cent
solution, in 6.67 2.79 per cent with the 0.004 per cent solution, in 5.0 2.44
per cent with the 0.002 per cent solution, etc. (table 1). Since, in these patients,
there is no disease attributable to ragweed pollens, the specific skin reactions
are of no clinical significance with respect to presenting symptoms.
Allergic skin reactions were obtained in patients in the fall hay fever and/or
asthma series in 97.78 2.20 per cent of cases with the 0.02 and 0.004 per cent
solutions, in 95.56 3.07 per cent with the 0.002 and 0.001 per cent solutions,
in 86.67 5.07 per cent with the 0.0002 per cent solutions, etc. (table 1).
Diagnostic reactions are those which constitute the clinically significant frac-
tion of the total number of positive reactions obtained with extracts. All the
reactions produced by non-irritant concentrations of extracts are presumably
allergic, but those occuring in control patients (individuals who have no symp-
toms attributable to allergic disease) are devoid of diagnostic significance with
respect to concurrent symptoms. The latter reactions must be taken into
account when the diagnostic efficiency of positive reactions is estimated. The
diagnostic efficiency of the positive skin reactions obtained with a given con-
centration of ragweed extract is equal to the percentage of positive reactions
obtained in the patients with fall hay fever and/or asthma divided by the sum
of the percentage of positive reactions in these patients and the percentage of
positive reactions in control patients. The diagnostic efficiency of the positive
reactions obtained with the nine concentrations of the extract did not differ
significantly (table 2).
If it is assumed that in this locality all cases of fall hay fever, asthma, or both,
are caused by sensitivity to ragweed pollens, the sensitiveness of this extract
for demonstrating clinical sensitivity may be determined. On the basis of this
hypothesis the expected incidence of positive reactions can be compared with
the incidence observed. The observed incidence of positive reactions to the
0.02, 0.004, 0.002, and the 0.001 per cent solutions was not significantly different
from the incidence expected (Table 3). The observed incidence of positive
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TABLE 1
Incidence and analysis of reactions
STANDARD
CONCENTRATION SERIES NO. POSITIVE NO. NEGATIVE POSITIVE ERROR OP I"OF EXTRACT PERCENTAGE
per cent per cent
Control 8 72 10.00 3.35
.02 Less than .01Allergic 44 1 97.78 2.20
Control 5 75 6.67 2.79
.004 Less than .01Allergic 44 1 97.78 2.20
Control 4 76 5.00 2.44
.002 Less than .01Allergic 43 2 95.56 3.07
Control 3 77 3.75 2.12
.001 Less than .01Allergic 43 2 95.56 3.07
Control 3 77 3.75 2.12
.0002 Less than .01Allergic 39 6 86.67 5.07
Control 2 78 2.50 1.75
.0001 Less than .01Allergic 34 11 75.56 6.41
Control 2 78 2.50 1.75
.00002 Less than .01Allergic 31 14 68.89 6.90
Control 2 78 2.50 1.75
.00001 Less than .01Allergic 28 17 62.22 7.25
Control 1 79 1.25 1.24
.000001 Less than .01Allergic 12 33 26.67 6.59
* The probability is estimated by the Chi-Square Statistic. Analysis of these data by
the method of the difference between two proportions also yields significant probability
values.
TABLE 2
Diagnostic efficiency of the positive skin reactions
CONCENTRATION
OS EXTRACT
POSITIVE IN
CONTROL
PATIENTS
STANDARD
ERROR OF
PERCENTAGE
POSITIVE IN
PALL HAY
FEVER-ASTEMA
PATIENTS
STANDARD
ERROR OF
PERCENTAGE
DIAGNOSTIC
EFFICIENCY
STANDARD
ERROR OP
PERCENTAGE
per cent per cent per cent per cent
.02 10.00 3.35 97.78 2.20 90.72 2.90
.004 6.67 2.79 97.78 2.20 93.61 2.45
.002 5.00 2.24 95.56 3.07 95.03 2.17
.001 3.75 2.12 95.56 3.07 96.22 1.91
.0002 3.75 2.12 86.67 5.07 95.85 1.99
.0001 2.50 1.75 75.56 6.41 97.17 1.66
.00002 2.50 1.75 68.89 6.90 96.44 1.85
.00001 2.50 1.75 67.22 7.25 93.05 2.54
.000001 1.25 1.24 26.67 6.59 95.52 2.07
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skin reactions to the weaker solutions was significantly different from the ex-
pected incidence (table 3). The conclusion was therefore drawn that intra-
cutaneous tests with 0.02, 0.004, 0.002, and 0.001 per cent solutions of purified
extract demonstrated clinical sensitivity to ragweed pollens in all but a statis-
tically insignificant proportion of patients.
TABLE 3
Expected and observed incidence of positive skin reactwns in fall hayfever and/or
asthma patients
CONCENTRATION
OP EXTRACT NO. POSITIVE NO. NEGATIVE TOTAL P
* The exact probability was calculated from a tetrachoric table by direct combinatorial
methods.
The diagnostic efficiency of the positive reactions obtained with intracutaneous
tests with 0.004 to 0.000001 per cent solutions was not significantly different
from that obtained by scratch tests with 0.85 to 0.25 per cent solutions of purified
ragweed pollen extract.
Reactions obtained with intracutaneous tests with 0.02 to 0.00 1 per cent
solutions and those obtained with scratch tests with 0.85 to 0.50 per cent solu-
tions were comparable with respect to the sensitiveness of the extract in demon-
strating the clinical sensitivity presumed to be present.
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SUMMARY
1. Forty-five patients whose symptoms could be attributed to ragweed pollen
allergy, and 80 non-sensitive patients used for controls were subjected to intra-
cutaneous tests with 0.02 to 0.000001 per cent solutions of purified ragweed
pollen extract.
2. The incidence of positive reactions in patients with fall hay fever, asthma,
or both, was significantly greater than in patients in the control series; the con-
clusion was therefore drawn that these reactions were on an allergic basis.
3. On the assumption that in this locality all cases of fall hay fever, asthma or
both, are caused by ragweed pollens, intracutaneous tests with 0.02, 0.004, 0.002,
and 0.001 per cent solutions of purified ragweed pollen extracts demonstrated
the clinical sensitivity to these pollens of all but a statistically insignificant
proportion of these patients.
4. Positive intracutaneous tests with the nine solutions of purified ragweed
pollen extracts were diagnostic of allergic disease attributable to ragweed pollens
in 90.72 2.90 per cent to 97.17 1.99 per cent of instances in which they
occurred.
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